Fact-checked by Grok 2 weeks ago

Lithium bromide

Lithium bromide (LiBr) is an composed of cations and anions, appearing as a white, deliquescent, and highly hygroscopic crystalline solid with a slightly bitter taste. It has a molecular weight of 86.85 g/mol, a of approximately 550 °C, and a of about 1265 °C, and it exhibits exceptional in (up to 166.7 g/100 mL at 20 °C), as well as in alcohols, ethers, and glycols. Typically prepared by the reaction of (Li₂CO₃) or (LiOH) with (HBr) in , followed by evaporation and crystallization, lithium bromide is produced on an industrial scale for various applications. Its most prominent use is as an absorbent in lithium bromide-water absorption refrigeration systems, where it facilitates cooling by absorbing water vapor, enabling efficient and industrial chilling without mechanical compression; these systems are particularly valued for utilizing or . In , it serves as a for bromination reactions, halide exchange (e.g., converting iodoethane to ), and as a catalyst in organic transformations like . Historically, lithium bromide was employed as a and agent in the late 19th and early 20th centuries for treating conditions like anxiety and , though its use declined due to risks of —a involving neurological symptoms from bromide accumulation—and the advent of safer lithium salts like for psychiatric applications. Today, it finds niche roles as a in certain formulations and in settings for protein solubilization or as a in material preparation. Safety concerns include its irritant effects on and eyes, potential for allergic reactions, and moderate oral (LD50 of 1800 mg/kg in rats), necessitating handling with protective equipment to avoid or .

History

Discovery and synthesis

Lithium, the elemental basis for lithium bromide, was discovered in 1817 by Johan Arfwedson during his analysis of the (LiAlSi₄O₁₀) sourced from a mine on the island of Utö, . Arfwedson identified an component that did not match known elements like sodium or , marking the first recognition of as a distinct substance. Working in the laboratory of prominent chemist , Arfwedson sought Berzelius's confirmation, which came through independent verification of the new element's presence in and other minerals like . Berzelius coined the name "" from the Greek word lithos, meaning "stone," to emphasize its origin in mineral sources, distinguishing it from other alkali metals typically derived from plant ashes. The first isolation of metallic occurred in 1821, achieved by British chemist William Thomas Brande via of , producing small quantities of the reactive, silvery-white metal. This milestone enabled further exploration of lithium compounds. Lithium bromide was likely first synthesized in the mid-19th century, following the 1826 discovery of by Jérôme Balard, through reactions involving lithium salts such as or with or . Although the precise date of its initial preparation remains undocumented, the first documented uses appear in by 1870, coinciding with growing interest in halides for analytical and medicinal purposes. By the 1870s, lithium bromide had entered medical practice as a and .

Early medical and industrial applications

Lithium bromide's early medical applications began in the mid-19th century, influenced by the 1859 discovery by Alfred Baring Garrod that lithium salts, including urates, exhibited high solubility in treating uric acid-related conditions like , which paved the way for broader explorations of lithium compounds in therapeutics. This foundational insight encouraged the investigation of lithium bromide specifically for neurological and psychiatric uses. In , American neurologist Silas Weir Mitchell pioneered its psychiatric application, recommending lithium bromide as an and for and general nervousness, marking the first documented use in this domain. By the late , lithium bromide saw widespread adoption as a and , particularly for managing and , often administered in the form of salts dissolved in tonics or elixirs for easier . In 1871, New York William A. Hammond further advanced its use by prescribing high oral doses of lithium bromide for acute and melancholia, highlighting its calming effects on agitated states. These applications persisted into the early 20th century, reflecting its versatility in both psychiatric and metabolic treatments. Industrial adoption of lithium bromide emerged around , leveraging its extreme hygroscopic properties to serve as an absorbent in absorption refrigeration systems for , following studies by companies like and Servel. These systems utilized lithium bromide's ability to absorb for dehumidification and cooling in industrial environments requiring precise moisture regulation, with commercial development in the late . Medical use of lithium bromide declined sharply by the 1940s amid growing concerns over its toxicity, including reports of severe side effects from bromide accumulation () and improper dosing, which overshadowed its benefits. This led to its replacement by safer lithium salts like for psychiatric applications. Separately, in 1949, Australian psychiatrist introduced as an effective treatment for , reviving lithium therapy without the bromide-related risks.

Properties

Physical properties

Lithium bromide has the LiBr and a molecular weight of 86.845 g/mol. It exists as a white to off-white crystalline solid that is highly hygroscopic and deliquescent, readily absorbing moisture from the air to form hydrated species. The form exhibits a of 3.464 g/cm³ at 25 °C, a of 552 °C, and a of 1,265 °C. Lithium bromide demonstrates exceptional solubility in , increasing markedly with , as shown in the following table:
(°C) (g/100 mL )
0143
20166.7
100266
It is also soluble in ethanol and ether. The crystal structure of anhydrous lithium bromide is cubic, akin to that of sodium chloride, with space group Fm\overline{3}m. In aqueous solutions, lithium bromide exhibits strong hydration tendencies, forming stable hydrates such as LiBr·H₂O, LiBr·2H₂O, and LiBr·3H₂O. The dissolution of lithium bromide in water is an exothermic process with a high heat of solution, releasing significant thermal energy. This hygroscopic nature contributes to its utility in absorption refrigeration systems, where it efficiently absorbs water vapor.

Chemical properties

Lithium bromide is an ionic compound composed of the lithium cation (Li⁺) and the bromide anion (Br⁻), characterized by strong electrostatic bonding arising from the high charge density of the small Li⁺ ion, which is the highest among monovalent cations at approximately 52 C·mm⁻³. This ionic lattice results in a cubic crystal structure similar to sodium chloride, with lattice parameter a = 5.489 Å. The Li⁺ cation exhibits Lewis acid behavior due to its electron-deficient nature and high , enabling it to act as a hard Lewis acid in coordination chemistry by forming complexes with Lewis bases, particularly in non-aqueous solvents such as (THF), where it coordinates with oxygen atoms to stabilize organolithium or catalyze reactions like openings. This coordination enhances the compound's utility in synthetic applications by promoting selective activation of substrates. Lithium bromide demonstrates good stability under normal conditions, remaining unreactive in air, but it is incompatible with strong oxidizing agents, which can lead to hazardous reactions involving oxidation. At elevated temperatures, thermal decomposition can produce , , and lithium oxides. Due to the strong coordinating ability of Li⁺, lithium bromide readily forms hydrated salts, such as the dihydrate (LiBr·2H₂O), where molecules are tightly bound to the cation through ion-dipole interactions, contributing to its extreme hygroscopicity. This is reversible and plays a key role in its applications as a . Spectroscopically, lithium bromide exhibits characteristic infrared (IR) absorption for the Li-Br stretching mode as a broad band with a maximum around 170 cm⁻¹, reflecting the ionic bonding and lattice vibrations. Nuclear magnetic resonance (NMR) studies utilize ⁷Li (100% natural abundance, I = 3/2) for probing lithium environments in solutions and solids, often showing shifts indicative of coordination, while ⁸¹Br (50.5% abundance, I = 3/2) NMR and nuclear quadrupole resonance (NQR) reveal bromide dynamics in ionic conductors like LiAlBr₄. Aqueous solutions of lithium bromide are , with a near 7, as the strong acid-base parentage (HBr and LiOH) results in minimal of either ion.

Production

Laboratory preparation

Lithium bromide can be synthesized in the laboratory by reacting with in an aqueous suspension. The balanced chemical equation for this reaction is: \text{Li}_2\text{CO}_3 + 2\text{HBr} \rightarrow 2\text{LiBr} + \text{CO}_2 + \text{H}_2\text{O} The procedure typically involves slowly adding a solution of hydrobromic acid to finely powdered lithium carbonate while stirring vigorously to facilitate the evolution of carbon dioxide gas. The mixture is heated gently if necessary to complete the reaction, after which any undissolved solids are removed by filtration. The filtrate is then concentrated by evaporation under reduced pressure to yield crude lithium bromide as a hydrate. An alternative laboratory method utilizes reacted with . The balanced equation is: \text{LiOH} + \text{HBr} \rightarrow \text{LiBr} + \text{H}_2\text{O} In this approach, is added to a solution of . The resulting solution is filtered to eliminate any precipitates and evaporated to isolate the product. This method is useful when other reagents are preferred. Purification of the crude lithium bromide is achieved through recrystallization from hot , exploiting its high in this (approximately 70 g/100 mL at 15°C), followed by cooling to promote formation. The crystals are collected by and dried. For the form, the purified is subjected to drying at elevated temperatures (around 100–150°C) to remove of without . These preparations are suited for small-scale synthesis, typically yielding gram quantities of product with efficiencies of 80–95% based on the limiting reactant. Analytical verification involves argentometric to confirm bromide ion concentration or to identify characteristic Li–Br vibrational bands. Due to the production of toxic fumes and the corrosiveness of reagents, all reactions must be performed in a well-ventilated with appropriate .

Industrial production

Lithium bromide is primarily produced on an industrial scale by reacting (derived from brines or ores) or with . Lithium carbonate sources often come from lithium-rich brines, such as those from the in . The core process entails reacting the lithium compound with (HBr) or (Br₂) in solution, producing lithium bromide and by-products such as or ; the latter is often recovered. Global annual production was estimated at around 10,000 tons as of 2023, with growth driven by increasing lithium demand; leads in production and consumption. This production benefits from integrated s in regions with and resources. Commercial grades typically achieve purities exceeding 99%, suitable for applications in and . Major producers include and Ajay-SQM (a involving SQM). The overall for lithium bromide has expanded since 2020, fueled by growth in electric vehicles and storage.

Uses

Absorption refrigeration and air conditioning

Lithium bromide serves as the primary absorbent in water-lithium bromide (LiBr-H₂O) vapor refrigeration systems, typically at concentrations of 50-60% by weight, where it efficiently absorbs to enable heat-driven cooling in chillers. In these systems, acts as the , evaporating at low temperatures under to produce chilled , while the hygroscopic LiBr solution facilitates the process without requiring mechanical compression. The absorption cycle operates through four main components: the , , , and absorber. In the , —often from waste s—is applied to the dilute LiBr (rich in water) to desorb water , concentrating the ; the then condenses in the , releasing . The concentrated LiBr flows to the absorber, where it reabsorbs water from the , diluting itself and generating cooling; a between the strong and weak solutions improves efficiency. The (COP) for these systems typically ranges from 0.7 to 1.2, with single-effect units around 0.7-0.8 and double-effect units exceeding 1.0, depending on source and configuration. These chillers are widely applied in large-scale (HVAC) systems for commercial buildings and networks, where centralized plants deliver chilled to multiple facilities. bromide-based systems hold approximately 92% of the global absorption chiller , dominating due to their reliability in high-capacity applications. Key advantages include the ability to utilize low-grade , , or geothermal sources for operation, reducing electricity consumption and enabling integration with systems. However, a notable disadvantage is the risk of LiBr at low temperatures below 5°C, which can occur if the solution cools excessively during startup, shutdown, or low-load conditions, potentially blocking components and requiring dilution cycles for recovery. Commercial adoption of lithium bromide absorption chillers began in the mid-20th century, with Carrier Corporation introducing the first large-scale units in 1945 following studies in the early , and widespread commercialization occurring in the .

Medical applications

Lithium bromide was historically employed as a and antimanic agent from the to the , particularly for treating , , and , with American physician William A. Hammond recommending massive oral doses for acute manic episodes. Its therapeutic effects were attributed to the lithium ion's modulation of neurotransmitter systems, including serotonin and norepinephrine, which helped stabilize mood and reduce excitability in psychiatric conditions. Early adoption included its use as a and antianxiety agent, with neurologist Weir Mitchell promoting it for and general nervousness in 1870. Pharmacokinetically, lithium bromide is rapidly absorbed after , achieving peak levels within 1-2 hours, with a of approximately 22-24 hours, and primarily excreted unchanged via the kidneys. Common side effects encompassed gastrointestinal disturbances, , tremors, and dysfunction, such as , which arose from the compound's impact on balance and hormonal regulation. These adverse effects, compounded by reports of and fatalities—often due to unmonitored dosing—prompted the U.S. (FDA) to withdraw approval for its psychiatric use in 1949, effectively halting its medicinal application in humans. Today, lithium bromide is obsolete in human , supplanted by safer formulations like , which offers better tolerability and monitoring capabilities. It sees limited minor application in veterinary contexts or as a precursor for therapies, though predominates in such roles. Ongoing research occasionally explores lithium bromide's potential neuroprotective properties, such as reducing risk through neuronal stabilization, but remains the preferred agent, with no FDA-approved human therapies involving lithium bromide as of 2025. Historically, it was administered in aqueous solutions or tablets at doses typically ranging from 0.3 to 1 g per day for mood stabilization.

Organic synthesis and other industrial uses

Lithium bromide serves as a source of ions in , facilitating reactions where the acts as a or leaving group counterpart. In particular, it is employed in (THF) to enhance the reactivity of Grignard reagents, promoting faster formation and improving yields in carbon-carbon bond-forming reactions by solubilizing magnesium species and accelerating halide exchange. Additionally, lithium bromide functions as an additive in Suzuki-Miyaura cross-coupling reactions, where it stabilizes organoborane intermediates derived from lithium borates, enabling efficient coupling of aryl or vinyl halides with derivatives under mild catalysis conditions. In industrial catalysis, lithium bromide is utilized for the purification of steroids and prostaglandins through selective techniques, leveraging its properties to isolate these compounds from complex reaction mixtures by forming bromide adducts that precipitate impurities while leaving the target molecules in solution. This method is particularly effective in , where high selectivity minimizes side products and improves overall process efficiency for these bioactive molecules. Beyond synthesis, lithium bromide finds application as a for drying gases in , absorbing moisture from air streams or to prevent corrosion and ensure product quality due to its strong hygroscopic nature. It is also incorporated into fluids for , where it helps stabilize boreholes by controlling fluid density and inhibiting swelling in high-pressure environments. Furthermore, lithium bromide acts as a in metal joining operations, lowering the of oxides on surfaces to promote and strong bonds during of alloys like aluminum and magnesium. A notable specific reaction involves lithium bromide catalyzing the of ethers in acidic concentrated lithium bromide solutions, such as those with , where it promotes selective breaking of aryl ether bonds under mild heating (around 100°C), yielding and alkyl bromides with high efficiency, as demonstrated in lignin depolymerization studies. Global lithium bromide production includes allocation to chemical and industrial applications outside , requiring purities ranging from 98% for general uses to 99.9% for high-precision and to avoid impurities affecting reaction outcomes.

Emerging applications

Recent research in 2024 has introduced static lithium-bromide batteries leveraging the for two-electron transfer, achieving an of 2180 Wh kg⁻¹ based on mass and demonstrating over 1000 cycles of stability with a 3.8 V plateau. This design, featuring an active salt cathode and tailored electrolytes with NO₃⁻ and Cl⁻ additives, positions lithium bromide as a promising material for stationary due to its high capacity (653 mAh g⁻¹ Br) and minimal capacity fade (4.4% per 100 cycles). In absorption systems, 2025 investigations have focused on integrating ionic liquids with lithium bromide to mitigate issues, enhancing and for recovery in automotive and applications. For example, [EMIM][OAc] extends the liquid-phase composition of LiBr-H₂O solutions to x₁ = 0.2697 at 303.15 K, compared to 0.2509 in pure , while [EMIM]Br and [BMIM]Br provide similar benefits through anion hydration effects. These additives broaden the temperature range for absorption , reducing maintenance needs and improving overall system performance. Additional studies in 2023 have examined nanoparticle additives in LiBr-H₂O solutions for chillers, where Fe₂O₃ nanoparticles (0.2 wt%) combined with surfactants like SDBS reduce viscosity, facilitating better heat and mass transfer in falling film absorbers. Complementing this, 2025 experimental modeling of mass transport in LiBr-H₂O has elucidated coupling between diffusion, thermodiffusion, and composition gradients, enabling optimized flow dynamics for enhanced absorption efficiency. Emerging potential includes lithium bromide's role as a in for heat recovery and dehumidification, driven by regulatory support for sustainable applications. Furthermore, recovery of lithium from LiBr waste via bipolar achieves 99% conversion to , with current efficiencies up to 91.61% under optimized conditions (0.3 /L, 30 /cm²). However, scalability and cost barriers persist, limiting these innovations to stages with no deployments as of 2025.

Hazards and environmental impact

Health and safety hazards

Lithium bromide causes skin irritation and serious eye irritation upon contact. It is also , with an acute oral LD50 of 1.8 g/kg in rats, leading to gastrointestinal distress including , , and . Ingestion can result in systemic effects such as and muscular weakness due to lithium ion absorption. Chronic exposure to lithium bromide may cause from the lithium ion, manifesting as , , and . Bromide accumulation can lead to , characterized by skin rashes, , and neurological impairments at high doses. Inhalation of lithium bromide dust irritates the , potentially causing coughing and . Its dissolution in water is highly exothermic, generating heat and that can exacerbate hazards or cause burns. Safe handling requires , including gloves, safety goggles, and protective clothing, to prevent skin and eye contact. It should be stored in sealed containers in a cool, dry, well-ventilated area away from moisture to avoid unintended reactions. OSHA has not established a specific (PEL) for lithium bromide, though has a PEL of 0.025 mg/m³ as . In the , it is classified as a irritant (H315) and causes serious eye irritation (H319). Historically, lithium bromide was used in sedatives, but its prompted discontinuation in favor of safer alternatives.

Environmental considerations

Lithium bromide, upon release into the , dissociates into cations and anions, both of which exhibit high in aqueous systems without the persistence typical of compounds. The ion is chemically stable and does not undergo , but as a naturally occurring , it disperses and integrates into biogeochemical cycles without long-term accumulation as a . ions similarly show low environmental persistence, mobilizing readily in and demonstrating minimal in aquatic organisms, with concentrations in marine species typically remaining below 10 mg/kg dry weight across various taxa. In terms of direct ecological impact, lithium bromide has zero ozone depletion potential (ODP) and a global warming potential (GWP) of less than 1, making it a favorable alternative in applications like absorption refrigeration that historically relied on chlorofluorocarbons. Aquatic toxicity assessments indicate low to moderate effects, with an LC50 of 438 mg/L for rainbow trout (Oncorhynchus mykiss) over 96 hours and an EC50 of 364 mg/L for invertebrates over 48 hours, classifying it as non-highly toxic under standard criteria. However, elevated concentrations can induce salinity stress in freshwater ecosystems, potentially disrupting osmoregulation in sensitive species at levels exceeding 500 mg/L. Waste management practices emphasize recycling to mitigate environmental release, such as the 2021 bipolar membrane electrodialysis (BMED) process that recovers over 90% of from spent lithium bromide solutions as , enabling reuse in industrial applications. Complementary methods, including those using aluminum-based precipitants, achieve lithium recovery rates up to 95% from dilute brines at molar ratios as low as 4:1. Environmental guidelines, including those from the U.S. Environmental Protection Agency (EPA), recommend avoiding direct discharge into waterways to prevent localized increases, aligning with broader regulations under the Clean Water Act that classify such salts as potential contributors to effluent limitations. The lifecycle of lithium bromide production begins with lithium extraction from brine deposits, which consumes significant water resources—typically 100–800 m³ per tonne of lithium carbonate equivalent—potentially straining arid regions where operations occur. In use, absorption systems employing lithium bromide indirectly reduce environmental harm by displacing ozone-depleting refrigerants, avoiding millions of tonnes of equivalent emissions annually. Sustainability initiatives as of 2025 include advancing closed-loop recycling protocols, such as reversible denaturation processes that recover and lithium bromide solutions with over 95% , minimizing generation. Globally, lithium salts like lithium bromide are regulated under the Union's REACH framework, which mandates registration, risk assessments, and safe handling to ensure minimal throughout the supply chain.